Epidemiology of cholangiocarcinoma

Author(s): Bergguist A, von Seth E


AIM: To investigate the prognostic value of metastatic lymph node ratio (MLNR) in extrahepatic cholangiocarcinoma (ECC) patients undergoing radical resection. METHODS: Seventy-eight patients with ECC were enrolled. Associations between various clinicopathologic factors and prognosis were investigated by Kaplan-Meier analyses. The Cox proportional-hazards model was used for multivariate survival analysis. RESULTS: The overall three- and five-year survival rates were 47.26% and 23.99%, respectively. MLNR of 0, 0-0.2, 0.2-0.5, and > 0.5 corresponded to five-year survival rates of 28.59%, 21.60%, 18.84%, and 10.03%, respectively. Univariate analysis showed that degree of tumor differentiation, lymph node metastasis, MLNR, tumor-node-metastasis (TNM) stage, and margin status were closely associated with postoperative survival in ECC patients (P < 0.05). Multivariate analysis showed that MLNR and TNM stage were independent prognostic factors after pancreaticoduodenectomy (HR = 2.13, 95%CI: 1.45-3.11; P < 0.01; and HR = 1.97, 95%CI: 1.17-3.31; P = 0.01, respectively). The median survival time for MLNR > 0.5, 0.2-0.5, 0-0.2, and 0 was 15 mo, 24 mo, 23 mo, and 35.5 mo, respectively. There were statistical differences in survival time between patients with different MLNR (χ2 = 15.38; P < 0.01). CONCLUSION: MLNR is an independent prognostic factor for ECC patients after radical resection and is useful for predicting postoperative survival.

Similar Articles

Clinicopathological significance of fatty acid synthase expression in carcinoma of the Ampulla of Vater

Author(s): Maekawa H, Ito T, Kushida T, Orita H, Sakurada M, et al.

Cancer Review: Cholangiocarcinoma

Author(s): Ghouri YA, Mian I, Blechacz B

Prognostic impact of lymph node metastasis in distal cholangiocarcinoma

Author(s): Kiriyama M, Ebata T, Aoba T, Kaneoka Y, Arai T, et al.

Prognositc factors for survival after curative resection of distal cholangiocarcinoma

Author(s): Kim HJ, Kim CY, Hur YH, Koh YS, Kim JC, et al.

Prognostic factors in patients with middle and distal bile duct cancers

Author(s): Kwon HJ, Kim SG, Chun JM, Lee WK, Hwang YJ

Prognostic significance of overexpression of c-Met oncoprotein in cholangiocarcinoma

Author(s): Miyamoto M, Ojima h, Iwasaki M, Shimizu H, Kokubu A, et al.

Survival rate of extrahepatic cholangiocarcinoma patients after surgical treatment in Thailand

Author(s): Pattanathien P, Khuntikeo N, Promthet S, Kamsa-Ard S

Distal cholangiocarcinoma

Author(s): Lad N, Kooby DA